Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice

Journal of Nutritional Biochemistry

Volumn 30, Issue , 2016, Pages 93-101

  Norris, Gregory H ^a   Jiang, Christina ^a   Ryan, Julia ^a   Porter, Caitlin M ^a   Blesso, Christopher N ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Cholesterol; Gut microbiota; High fat diet; Lipid metabolism; Milk; Sphingomyelin

Indexed keywords

ABC TRANSPORTER G5; ACYL COENZYME A DESATURASE 1; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; APOLIPOPROTEIN A4; CHOLESTEROL; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; FATTY ACID BINDING PROTEIN 2; GLUCOSE; INDUCIBLE DEGRADER OF THE LDL RECEPTOR; LIPID; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MILK FAT; MILK SPHINGOMYELIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OCCLUDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; PROTEIN ZO1; SERINE PROTEINASE; SPHINGOMYELIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME INDUCTION; EPIDIDYMAL WEIGHT; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; FECES MICROFLORA; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GRAM NEGATIVE BACTERIUM; INTESTINE FLORA; LIPID DIET; LIPID METABOLISM; LIVER WEIGHT; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN; ANIMAL; INTESTINE; METABOLISM; MICROBIOLOGY; MILK;

ANIMALS; DIET, HIGH-FAT; GASTROINTESTINAL MICROBIOME; INTESTINES; LIPID METABOLISM; MILK; SPHINGOMYELINS;

EID: 84962068344     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.12.003     Document Type: Article

References (55)

1. Schrauwen P., Westerterp K.R. The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 2000, 84:417-427.
2. Hariri N., Thibault L. High-fat diet-induced obesity in animal models. Nutr Res Rev 2010, 23:270-299.
3. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
4. Ding S., Lund P.K. Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 2011, 14:328-333.
5. Neal M.D., Leaphart C., Levy R., Prince J., Billiar T.R., Watkins S., et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006, 176:3070-3079.
6. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50:90-97.
7. Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Palú G., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G518-G525.
8. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
9. Murphy E.F., Cotter P.D., Healy S., Marques T.M., O'Sullivan O., Fouhy F., et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010, 59:1635-1642.
10. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
11. Howell W.H., McNamara D.J., Tosca M.A., Smith B.T., Gaines J.A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 1997, 65:1747-1764.
12. Subramanian S., Han C.Y., Chiba T., McMillen T.S., Wang S.A., Haw A., et al. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:685-691.
13. Subramanian S., Goodspeed L., Wang S., Kim J., Zeng L., Ioannou G.N., et al. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 2011, 52:1626-1635.
14. Wouters K., van Gorp P.J., Bieghs V., Gijbels M.J., Duimel H., Lütjohann D., et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008, 48:474-486.
15. Noh S.K., Koo S.I. Egg sphingomyelin lowers the lymphatic absorption of cholesterol and alpha-tocopherol in rats. J Nutr 2003, 133:3571-3576.
16. Noh S.K., Koo S.I. Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. J Nutr 2004, 134:2611-2616.
17. Eckhardt E.R., Wang D.Q., Donovan J.M., Carey M.C. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002, 122:948-956.
18. Duivenvoorden I., Voshol P.J., Rensen P.C., van Duyvenvoorde W., Romijn J.A., Emeis J.J., et al. Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice. Am J Clin Nutr 2006, 84:312-321.
19. Ohlsson L., Hertervig E., Jonsson B.A., Duan R.D., Nyberg L., Svernlöv R., et al. Sphingolipids in human ileostomy content after meals containing milk sphingomyelin. Am J Clin Nutr 2010, 91:672-678.
20. Garmy N., Taieb N., Yahi N., Fantini J. Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J Lipid Res 2005, 46:36-45.
21. Sprong R.C., Hulstein M.F., Van der Meer R. Bactericidal activities of milk lipids. Antimicrob Agents Chemother 2001, 45:1298-1301.
22. Vesper H., Schmelz E.M., Nikolova-Karakashian M.N., Dillehay D.L., Lynch D.V., Merrill A.H. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 1999, 129:1239-1250.
23. Nyberg L., Duan R.D., Nilsson A. A mutual inhibitory effect on absorption of sphingomyelin and cholesterol. J Nutr Biochem 2000, 11:244-249.
24. Ramstedt B., Leppimaki P., Axberg M., Slotte J.P. Analysis of natural and synthetic sphingomyelins using high-performance thin-layer chromatography. Eur J Biochem 1999, 266:997-1002.
25. Jensen R.G. The composition of bovine milk lipids: January 1995 to December 2000. J Dairy Sci 2002, 85:295-350.
26. Fedotova Y., Lencki R.W. The effect of phospholipids on milkfat crystallization behavior. J Am Oil Chem Soc 2008, 85:205-212.
27. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers 2005, Research CfDEa (Ed.).
28. Farrell N., Norris G., Lee S.G., Chun O.K., Blesso C.N. Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice. Food Funct 2015, 6:1278-1287.
29. Caporaso J.G., Lauber C.L., Walters W.A., Berg-Lyons D., Huntley J., Fierer N., et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012, 6:1621-1624.
30. Nelson M.C., Morrison H.G., Benjamino J., Grim S.L., Graf J. Analysis, optimization and verification of Illumina-generated 16S rRNA gene amplicon surveys. PLoS One 2014, 9.
31. An D., Na C., Bielawski J., Hannun Y.A., Kasper D.L. Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4666-4671.
32. Sampath H., Miyazaki M., Dobrzyn A., Ntambi J.M. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 2007, 282:2483-2493.
33. Murphy E.A., Velazquez K.T., Herbert K.M. Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care 2015, 18:515-520.
34. Duan R.D., Hertervig E., Nyberg L., Hauge T., Sternby B., Lillienau J., et al. Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci 1996, 41:1801-1806.
35. Liu J.J., Nilsson A., Duan R.D. In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase. Lipids 2002, 37:469-474.
36. Feng D., Ohlsson L., Ling W., Nilsson A., Duan R.D. Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells. Dig Dis Sci 2010, 55:3377-3383.
37. Garcia-Barros M., Coant N., Truman J.P., Snider A.J., Hannun Y.A. Sphingolipids in colon cancer. Biochim Biophys Acta 2014, 1841:773-782.
38. Olsson M., Duan R.D., Ohlsson L., Nilsson A. Rat intestinal ceramidase: purification, properties, and physiological relevance. Am J Physiol Gastrointest Liver Physiol 2004, 287:G929-G937.
39. Garmy N., Taieb N., Yahi N., Fantini J. Apical uptake and transepithelial transport of sphingosine monomers through intact human intestinal epithelial cells: physicochemical and molecular modeling studies. Arch Biochem Biophys 2005, 440:91-100.
40. Chung R.W., Kamili A., Tandy S., Weir J.M., Gaire R., Wong G., et al. Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. PLoS One 2013, 8.
41. Li Z., Basterr M.J., Hailemariam T.K., Hojjati M.R., Lu S., Liu J., et al. The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis. Biochim Biophys Acta 2005, 1735:130-134.
42. Ramprasath V.R., Jones P.J., Buckley D.D., Woollett L.A., Heubi J.E. Effect of dietary sphingomyelin on absorption and fractional synthetic rate of cholesterol and serum lipid profile in humans. Lipids Health Dis 2013, 12:125.
43. Alrefai W.A., Annaba F., Sarwar Z., Dwivedi A., Saksena S., Singla A., et al. Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2. Am J Physiol Gastrointest Liver Physiol 2007, 292:G369-G376.
44. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
45. Umemoto T., Subramanian S., Ding Y., Goodspeed L., Wang S., Han C.Y., et al. Inhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammation. J Lipid Res 2012, 53:2380-2389.
46. Thai M.V., Guruswamy S., Cao K.T., Pessin J.E., Olson A.L. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 1998, 273:14285-14292.
47. Handschin C., Rhee J., Lin J., Tarr P.T., Spiegelman B.M. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 2003, 100:7111-7116.
48. Haramizu S., Ota N., Otsuka A., Hashizume K., Sugita S., Hase T., et al. Dietary milk fat globule membrane improves endurance capacity in mice. Am J Physiol Regul Integr Comp Physiol 2014, 307:R1009-R1017.
49. Serino M., Luche E., Gres S., Baylac A., Berge M., Cenac C., et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012, 61:543-553.
50. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
51. Lievin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.R., et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000, 47:646-652.
52. Cummings J.H., Macfarlane G.T. Gastrointestinal effects of prebiotics. Br J Nutr 2002, 87(Suppl. 2):S145-S151.
53. Gauffin Cano P., Santacruz A., Moya A., Sanz Y. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One 2012, 7.
54. Wat E., Tandy S., Kapera E., Kamili A., Chung R.W., Brown A., et al. Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 2009, 205:144-150.
55. Zhou A.L., Hintze K.J., Jimenez-Flores R., Ward R.E. Dietary fat composition influences tissue lipid profile and gene expression in Fischer-344 rats. Lipids 2012, 47:1119-1130.